153 related articles for article (PubMed ID: 1593354)
1. Pituitary gigantism caused by growth hormone excess from infancy.
Gelber SJ; Heffez DS; Donohoue PA
J Pediatr; 1992 Jun; 120(6):931-4. PubMed ID: 1593354
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenoma associated with gigantism and hyperprolactinemia.
Alikasifoglu A; Kandemir N; Akalan N; Yordam N
Pediatr Neurosurg; 2001 Dec; 35(6):325-8. PubMed ID: 11786701
[TBL] [Abstract][Full Text] [Related]
4. Pituitary gigantism causing diabetic ketoacidosis.
Alvi NS; Kirk JM
J Pediatr Endocrinol Metab; 1999; 12(6):907-9. PubMed ID: 10614552
[TBL] [Abstract][Full Text] [Related]
5. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
Felix IA; Horvath E; Kovacs K; Smyth HS; Killinger DW; Vale J
Acta Neuropathol; 1986; 71(1-2):76-82. PubMed ID: 3776476
[TBL] [Abstract][Full Text] [Related]
6. Gigantism associated with a pituitary tumour secreting growth hormone and prolactin and cured by transsphenoidal hypophysectomy.
Favre L; Rogers LM; Cobb CA; Rabin D
Acta Endocrinol (Copenh); 1979 Jun; 91(2):193-200. PubMed ID: 223354
[TBL] [Abstract][Full Text] [Related]
7. Gigantism due to growth hormone excess in a boy with optic glioma.
Drimmie FM; MacLennan AC; Nicoll JA; Simpson E; McNeill E; Donaldson MD
Clin Endocrinol (Oxf); 2000 Oct; 53(4):535-8. PubMed ID: 11012581
[TBL] [Abstract][Full Text] [Related]
8. Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma.
Müssig K; Gallwitz B; Honegger J; Strasburger CJ; Bidlingmaier M; Machicao F; Bornemann A; Ranke MB; Häring HU; Petersenn S
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):198-202. PubMed ID: 17427111
[TBL] [Abstract][Full Text] [Related]
9. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
[TBL] [Abstract][Full Text] [Related]
10. Mammosomatotroph adenoma causing gigantism in an 8-year old boy: a possible pathogenetic mechanism.
Dubuis JM; Deal CL; Drews RT; Goodyer CG; Lagacé G; Asa SL; Van Vliet G; Collu R
Clin Endocrinol (Oxf); 1995 May; 42(5):539-49. PubMed ID: 7621575
[TBL] [Abstract][Full Text] [Related]
11. Pituitary gigantism.
Lu PW; Silink M; Johnston I; Cowell CT; Jimenez M
Arch Dis Child; 1992 Aug; 67(8):1039-41. PubMed ID: 1520009
[TBL] [Abstract][Full Text] [Related]
12. Endocrine evaluation and indications for surgery of functional pituitary adenomas.
Pearson OH; Brodkey JS; Kaufman B
Clin Neurosurg; 1974; 21():26-38. PubMed ID: 4370760
[No Abstract] [Full Text] [Related]
13. [Pituitary adenomas. Surgical treatment by transphenoidal approach].
Somma M; Rasio E; Beauregard H; Hardy J
Union Med Can; 1980 Jan; 109(1):68-81. PubMed ID: 6247803
[No Abstract] [Full Text] [Related]
14. The acromegaly--gigantism syndrome. Report of four cases treated surgically.
Zampieri P; Scanarini M; Sicolo N; Andrioli G; Mingrino S
Surg Neurol; 1983 Dec; 20(6):498-503. PubMed ID: 6648790
[TBL] [Abstract][Full Text] [Related]
15. Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy.
Ciresi A; Amato MC; Galluzzo A; Giordano C
J Endocrinol Invest; 2011 Feb; 34(2):162-3. PubMed ID: 21502798
[No Abstract] [Full Text] [Related]
16. Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy.
Bergamaschi S; Ronchi CL; Giavoli C; Ferrante E; Verrua E; Ferrari DI; Lania A; Rusconi R; Spada A; Beck-Peccoz P
Horm Res Paediatr; 2010; 73(1):74-9. PubMed ID: 20190543
[TBL] [Abstract][Full Text] [Related]
17. Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma.
Maheshwari HG; Prezant TR; Herman-Bonert V; Shahinian H; Kovacs K; Melmed S
J Clin Endocrinol Metab; 2000 Sep; 85(9):3409-16. PubMed ID: 10999842
[TBL] [Abstract][Full Text] [Related]
18. [Growth pituitary adenomas: evaluation of 20 patients].
Tella OI; Herculano MA; Delcello R; Aguiar PH
Arq Neuropsiquiatr; 2002 Mar; 60(1):123-8. PubMed ID: 11965421
[TBL] [Abstract][Full Text] [Related]
19. Pathological and experimental investigations in a case of gigantism.
Fazekas I; Pásztor E; Slowik F; Bálint K; Dobronyi I; Bácsy E; Gyévai A; Péter F; Blatniczky L; Varga I
Acta Neuropathol; 1993; 85(2):167-74. PubMed ID: 8382895
[TBL] [Abstract][Full Text] [Related]
20. [Gigantism caused by a double-secreting (GH-PRL) acidophile adenoma in a 6-year-old girl].
Rusconi R; Ballabio G; Piceni Sereni L
Minerva Pediatr; 1985 Oct; 37(20):815-9. PubMed ID: 3005820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
